Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
AUTOR(ES)
Gonias, Sara
FONTE
American Society of Clinical Oncology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2734428Documentos Relacionados
- Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy.
- Cardiomyopathy associated with high-dose interleukin-2 therapy.
- Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS.
- Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.
- High-Dose Intravenous Ribavirin Therapy for Subacute Sclerosing Panencephalitis